Browsing Tag
Anil Jain
7 posts
Bajaj Healthcare (NSE: BAJAJHCARE) Q3 FY26 earnings: API exports double, PAT up 34%
Bajaj Healthcare’s API exports doubled in Q3 FY26, driving 31% revenue growth. Find out what its CNS pipeline and CDMO ramp mean for future expansion.
Refex Group commissions Indian Railways’ largest solar power plant at Bhilai
India marks a significant milestone in its journey towards sustainability with the inauguration of the Indian Railways’ largest…
Bajaj Healthcare inaugurates India’s largest alkaloid extraction plant in Vadodara
Bajaj Healthcare Limited (BHL), a prominent name in the realm of APIs, Intermediates, and Formulations, has marked another…
Bajaj Healthcare launches Magnesium L-Threonate capsules
Bajaj Healthcare Limited (BHL), an Indian manufacturer of APIs, intermediates, and formulations, has launched Magnesium L-Threonate as part…
Bajaj Healthcare launches Covid drug 2-DG under DGJAJ brand
Bajaj Healthcare Limited (BHL) said that it has launched API and formulation of 2-Deoxy-D-Glucose (2-DG), an antiviral drug…
Bajaj Healthcare launches API of Black Fungus drug Posaconazole
Bajaj Healthcare Limited (BHL) has launched “Posaconazole API”, the active pharmaceutical ingredient (API) of the triazole antifungal agent…
Bajaj Healthcare launches Favijaj tablets for Covid-19 treatment in India
Bajaj Healthcare Limited (BHL) has launched Favijaj tablets, its generic version of Japan-based Fujifilm’s antiviral drug favipiravir for…